AGN
Argenica Therapeutics Limited
π¦πΊ ASX
π¦ LOGISTICS
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
+ 86.28%
Annual Growth
4 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
14
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Argenica Therapeutics Ltd. provides neuroprotective treatment. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2021-06-11. The firm's lead neuroprotective peptide candidate, ARG-007, has been demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischemic encephalopathy (HIE). The firm has initiated a Phase 2 clinical trial in acute ischemic stroke patients, as well as continuing to generate preclinical data in other neurological conditions.
π Performance
Price History
+320.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.84
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in AGN
14
π Total Capital Earnings
$19K
π Average investment frequency
28 weeks
π΅ Average investment amount
$2,688
β° Last time a customer invested in AGN
11 days
AGN investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
12%
100k - 150k
50k - 100k
41%
Less than 50k
35%
πΆ Age of investors
18 - 25
26 - 34
14%
35 - 90
86%
π Legal gender of investors
Female
71%
Male
29%
Pearlers who invest in AGN also invest in...
IVV
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
π Performance (5Yr p.a)
19.33%
π Share price
$62.90 AUD
πΊπΈ UNITED STATES
π HIGH PRICE GROWTH
NDQ
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
π Performance (5Yr p.a)
23.64%
π Share price
$49.99 AUD
π€ TECHNOLOGY
πΊπΈ UNITED STATES
π HIGH PRICE GROWTH
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
3.93%
π Share price
$102.17 AUD
𧱠MATERIALS
β³οΈ DIVERSIFIED
πΈ FINANCIALS
π¦πΊ AUSTRALIA
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
13.82%
π Share price
$140.84 AUD
π GLOBAL
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
π€ TECHNOLOGY
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
4.03%
π Share price
$69.12 AUD
β³οΈ DIVERSIFIED
π GLOBAL
Want more shares? Try these...